About Klinikum Würzburg Mitte gGmbH Standort Missioklinik
"Missioklinik und Juliusspital bilden gemeinsam das Klinikum Würzburg Mitte, ein modernes Klinikum mit zwei traditionsreichen Standorten. Als Krankenhaus der Schwerpunktversorgung bietet das KWM ein umfassendes medizinisches Behandlungsspektrum. Die mehr als 2.200 Mitarbeiter*innen des KWM versorgen jährlich etwa 30.000 Patienten."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Actelion
4
United Therapeutics
2
Hoffmann-La Roche
1
Clinical Trials at Klinikum Würzburg Mitte gGmbH Standort Missioklinik
During the past decade, Klinikum Würzburg Mitte gGmbH Standort Missioklinik conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
2021-02-26
2024-09-15
Active, not recruiting
10
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum Würzburg Mitte gGmbH Standort Missioklinik
According to Clinical.Site data, the most researched conditions in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are
"Pulmonary Arterial Hypertension" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials), "Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials). Many other conditions were trialed in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Würzburg Mitte gGmbH Standort Missioklinik
Most popular intervention types in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Selexipag" (2 trials), "Atezolizumab" (1 trials), "FDC macitentan/tadalafil" (1 trials) and "Macitentan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Würzburg Mitte gGmbH Standort Missioklinik
The vast majority of trials in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are
7 trials for "All" genders.
Clinical Trials Status at Klinikum Würzburg Mitte gGmbH Standort Missioklinik
Currently, there are NaN active trials in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinikum Würzburg Mitte gGmbH Standort Missioklinik,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Würzburg Mitte gGmbH Standort Missioklinik, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".